Alignment Healthcare (ALHC) Stock Price, News & Analysis

Company Overview

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

Key Stats

• Today's Range: $17.21 to $17.77
• 50-Day Range: $13.16 to $19.78
• 52-Week Range: $5.02 to $21.06
• Volume: 1.99 million shs
• Average Volume: 1.71 million shs
• Market Capitalization: $3.39 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $16.61
• Consensus Rating: Moderate Buy

Alignment Healthcare Stock Analysis - MarketRank™

Alignment Healthcare scored higher than 36% of companies evaluated by MarketBeat, and ranked 787th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Alignment Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 7 buy ratings, 3 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Alignment Healthcare has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Alignment Healthcare are expected to grow in the coming year, from ($0.69) to ($0.47) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Alignment Healthcare is -22.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Alignment Healthcare is -22.97, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Alignment Healthcare has a P/B Ratio of 21.06. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

9.82% of the float of Alignment Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Alignment Healthcare has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Alignment Healthcare has recently increased by 10.32%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Alignment Healthcare does not currently pay a dividend.

Dividend Growth

Alignment Healthcare does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

9.82% of the float of Alignment Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Alignment Healthcare has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Alignment Healthcare has recently increased by 10.32%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 3.4 / 5
• News Sentiment: 1.13

News Sentiment

Alignment Healthcare has a news sentiment score of 1.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.85 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 7 news articles for Alignment Healthcare this week, compared to 6 articles on an average week.

Search Interest

Only 6 people have searched for ALHC on MarketBeat in the last 30 days. This is a decrease of -14% compared to the previous 30 days.

MarketBeat Follows

4 people have added Alignment Healthcare to their MarketBeat watchlist in the last 30 days. This is an increase of 33% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Alignment Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $34,744,307.00 in company stock.

Percentage Held by Insiders

Only 6.60% of the stock of Alignment Healthcare is held by insiders.

Percentage Held by Institutions

86.19% of the stock of Alignment Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

ALHC Stock Analysis - Frequently Asked Questions

How have ALHC shares performed this year?

Alignment Healthcare's stock was trading at $11.25 at the beginning of 2025. Since then, ALHC stock has increased by 57.2% and is now trading at $17.69.
View the best growth stocks for 2025 here.

How were Alignment Healthcare's earnings last quarter?

Alignment Healthcare, Inc. (NASDAQ:ALHC) issued its quarterly earnings data on Tuesday, October, 29th. The company reported ($0.14) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.14). Alignment Healthcare's revenue was up 51.6% on a year-over-year basis.
Read the conference call transcript.

When did Alignment Healthcare IPO?

Alignment Healthcare (ALHC) raised $490 million in an initial public offering on Friday, March 26th 2021. The company issued 27,200,000 shares at $17.00-$19.00 per share. Goldman Sachs, Morgan Stanley, J.P. Morgan, BofA Securities and William Blair served as the underwriters for the IPO and UBS Investment Bank, Piper Sandler and Raymond James were co-managers.

Who are Alignment Healthcare's major shareholders?

Top institutional shareholders of Alignment Healthcare include Assenagon Asset Management S.A. (0.43%), Allspring Global Investments Holdings LLC (0.33%), Rhumbline Advisers (0.07%) and Principal Financial Group Inc. (0.05%). Insiders that own company stock include Atlantic (Aln Hlth) L General, Warburg Pincus Partners Gp Llc, Dawn Christine Maroney, John E Kao, Robert Thomas Freeman, Joseph S Konowiecki, Dinesh M Kumar, Robert L Scavo, Hyong Kim, Christopher J Joyce, Jeffrey H Margolis, Richard A Cross, Hakan Kardes, Sebastian Burzacchi and Andreas P Wagner.
View institutional ownership trends.

How do I buy shares of Alignment Healthcare?

Shares of ALHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Alignment Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Alignment Healthcare investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH), AUO (AUOTY), iShares Micro-Cap ETF (IWC) and Voyager Therapeutics (VYGR).

Company Calendar

• Last Earnings: 10/29/2024
• Today: 4/28/2025
• Next Earnings (Estimated): 5/01/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Hospital & medical service plans
• Sub-Industry: Insurance
• Current Symbol: NASDAQ:ALHC
• CIK: 1832466
• Web: www.alignmenthealthcare.com
• Phone: 844-310-2247
• Fax: N/A
• Employees: 850
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $16.61
• High Stock Price Target: $23.00
• Low Stock Price Target: $9.00
• Potential Upside/Downside: -6.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 12 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.68)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-148,020,000.00
• Net Margins: -5.84%
• Pretax Margin: -5.85%
• Return on Equity: -108.69%
• Return on Assets: -21.89%

Debt

• Debt-to-Equity Ratio: 1.82
• Current Ratio: 1.60
• Quick Ratio: 1.60

Sales & Book Value

• Annual Sales: $2.70 billion
• Price / Sales: 1.26
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.84 per share
• Price / Book: 21.06

Miscellaneous

• Outstanding Shares: 191,832,000
• Free Float: 179,044,000
• Market Cap: $3.39 billion
• Optionable: Optionable
• Beta: 1.32